Work

Oc.12.3 Sposib Sb2 – a Sicilian Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Infliximab Biosimilar Sb2 (flixabi®): Interim Analysis

FWCI:
Cites:
Cited by:
Related to: 10